Table 2 Immunophenotypic characterization of human adMSCs
Subject ID | CD44 | CD90 | CD105 | CD166 | CD73 | CD14 | CD34 | CD45 | CD106 | HLA-DR |
|---|---|---|---|---|---|---|---|---|---|---|
5898 | 95.5 | 91.3 | 97.2 | 94.0 | 98.6 | 0.5 | 33.6 | 0 | 1.7 | 0 |
5903 | 99.1 | 81.4 | 99.3 | 83.5 | 91.9 | 0 | 11.3 | 0 | 0.5 | 2.2 |
5919 | 98.8 | 98.1 | 99.3 | 99.3 | 93.9 | 0 | 6.6 | 1.2 | 7.1 | 3.0 |
5959 | 99.6 | 96.6 | 99.1 | 99.2 | 97.1 | 0 | 17.7 | 0.1 | 0.6 | 1.2 |
5982 | 99.0 | 98.0 | 99.2 | 99.1 | 93.9 | 0 | 8.1 | 0 | 0.9 | 0.3 |
6006 | 99.2 | 95.0 | 99.0 | 98.9 | 88.3 | 0.2 | 3.2 | 0 | 0.2 | 0 |
6008 | 97.3 | 95.9 | 99.4 | 99.6 | 94.6 | 0 | 3.5 | 1.7 | 1.2 | 6.7 |
6038 | 99.9 | 94.7 | 95.5 | 97.0 | 94.7 | 0 | 0.2 | 0.2 | 0 | 0.1 |
6111 | 98.4 | 96.9 | 95.9 | 93.3 | 86.7 | 0 | 0.1 | 0.5 | 0 | 0 |
6113 | 98.0 | 98.8 | 97.5 | 97.8 | 91.4 | 0 | 1.4 | 0.8 | 0.2 | 0 |